Safety Working Party documents
-
List item
CHMP SWP opinion on diethanolamine and coconut oil diethanolamine condensate as excipients (PDF/389.13 KB)
First published: 20/07/2021
EMA/275956/2021 -
List item
CHMP Safety Working Party’s response to CMDh questions on chlorobutanol (PDF/786.51 KB)
Adopted
First published: 17/03/2021
Last updated: 26/07/2021
EMA/CHMP/SWP/482438/2020 Corr.1 -
List item
Safety Working Party recommendations on the duration of contraception following the end of treatment with a genotoxic drug (PDF/1.01 MB)
First published: 01/04/2020
Last updated: 02/03/2022
EMA/CHMP/SWP/74077/2020 Corr.3 -
List item
CHMP Safety Working Party’s response to the PDCO regarding aluminium hydroxide contained in allergen products (PDF/248.86 KB)
Adopted
First published: 12/07/2011
Last updated: 12/07/2011
EMA/CHMP/381064/2010 -
List item
Guideline on non-clinical testing for inadvertent germline transmission of gene transfer vectors (PDF/112.84 KB)
Adopted
First published: 16/11/2006
Last updated: 16/11/2006
Legal effective date: 01/05/2007
EMEA/273974/2005 -
List item
Overview of comments received on a draft guideline on non-clinical testing for inadvertent germline transmission of gene transfer vectors(EMEA/273974/2005) (PDF/57.76 KB)
First published: 16/11/2006
Last updated: 16/11/2006
EMEA/360592/2006 -
List item
CHMP SWP Reflection Paper on PPARs (Peroxisome Proliferator Activated Receptors) (PDF/27.55 KB)
First published: 01/09/2006
Last updated: 01/09/2006
EMEA/341972/2006 -
List item
CHMP SWP reflection paper on the assessment of the genotoxic potential of antisense oligodeoxynucleotides (PDF/33.88 KB)
Adopted
First published: 20/01/2005
Last updated: 20/01/2005
EMEA/CHMP/SWP/199726/2004 -
List item
CHMP SWP conclusions and recommendations on the use of genetically modified animal models for carcinogenicity assessment - Revision 1 (PDF/238 KB)
Adopted
First published: 23/06/2004
Last updated: 23/06/2004
CPMP/SWP/2592/02 Rev 1